Regeneron Pharmaceuticals
REGN
REGN
578 hedge funds and large institutions have $27.9B invested in Regeneron Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 226 increasing their positions, 194 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 576 → 578 (+2)
0.29% less ownership
Funds ownership: 69.35% → 69.06% (-0.29%)
15% less call options, than puts
Call options by funds: $728M | Put options by funds: $852M
Holders
578
Holding in Top 10
17
Calls
$728M
Puts
$852M
Top Buyers
| 1 | +$2.31B | |
| 2 | +$244M | |
| 3 | +$188M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$181M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$173M |
Top Sellers
| 1 | -$465M | |
| 2 | -$448M | |
| 3 | -$261M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$108M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$91.8M |